Joseph Williams1, Linda Garvican2, Anna N A Tosteson3,4, David C Goodman3, Tracy Onega3,4. 1. Care Quality Commission, London, England. Joe.Williams@cqc.org.uk. 2. South East Coast Cancer Screening QA Reference Centre, Public Health England, Battle, England. 3. The Dartmouth Institute for Health Policy and Clinical Practice at the Dartmouth School of Medicine at Dartmouth, Lebanon, NH, USA. 4. Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Abstract
OBJECTIVES: Comparing breast cancer screening across countries within the context of some of the benefits and harms offers the opportunity to improve effectiveness through mutual learning. METHODS: This paper describes the provision of breast cancer screening in England and the United States. The various recommendations for accessing breast cancer screening in the two countries are set out and the organisation of services including quality assurance, incentives and performance mechanisms considered. RESULTS: In the United States, younger women are routinely screened; they are less likely to benefit and more likely to be harmed. The utilisation of breast cancer screening amongst eligible women is broadly comparable in the two countries. However, there are differences in technical performance; the reasons for these including radiological reading procedures and cultural factors are explored. CONCLUSIONS: Despite a well-functioning screening programme, breast cancer mortality and survival in England are poor relative to other countries. Emphasis for American improvement should be on reducing false-positive recall rates, while the English NHS could supplement existing efforts to understand and improve comparatively poor survival and mortality.
OBJECTIVES: Comparing breast cancer screening across countries within the context of some of the benefits and harms offers the opportunity to improve effectiveness through mutual learning. METHODS: This paper describes the provision of breast cancer screening in England and the United States. The various recommendations for accessing breast cancer screening in the two countries are set out and the organisation of services including quality assurance, incentives and performance mechanisms considered. RESULTS: In the United States, younger women are routinely screened; they are less likely to benefit and more likely to be harmed. The utilisation of breast cancer screening amongst eligible women is broadly comparable in the two countries. However, there are differences in technical performance; the reasons for these including radiological reading procedures and cultural factors are explored. CONCLUSIONS: Despite a well-functioning screening programme, breast cancer mortality and survival in England are poor relative to other countries. Emphasis for American improvement should be on reducing false-positive recall rates, while the English NHS could supplement existing efforts to understand and improve comparatively poor survival and mortality.
Entities:
Keywords:
Breast cancer; England; Mammography; Screening; United States
Authors: Alessandro Fancellu; Xue Yun Zhao; Pietrina Cottu; Valeria Sanna; Yuan Ping Li; Qin Zhu; Cinzia Tanda; Ying Yi Zhang; Yan Mei Lai; Giorgio Carlo Ginesu; Shu Qin Dai; Alberto Porcu Journal: Breast Care (Basel) Date: 2020-01-21 Impact factor: 2.860
Authors: Karen E Schifferdecker; Danielle Vaclavik; Karen J Wernli; Diana S M Buist; Karla Kerlikowske; Brian L Sprague; Louise M Henderson; Dianne Johnson; Jill Budesky; Gloria Jackson-Nefertiti; Diana L Miglioretti; Anna N A Tosteson Journal: Prev Med Date: 2021-06-30 Impact factor: 4.018
Authors: Jette J Bakhuizen; Helen Hanson; Karin van der Tuin; Fiona Lalloo; Marc Tischkowitz; Karin Wadt; Marjolijn C J Jongmans Journal: Fam Cancer Date: 2021-06-25 Impact factor: 2.446